Corixa is developing "immunologically smart" vaccines to attack specific antigens and initiate appropriate T cell response.
You may also be interested in...
Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.
The firms' messenger RNA alliance inked back on 2013 is still very much ongoing but AstraZeneca decided to sell its considerable stake in the high-profile biotech to help finance its own pipeline.
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.